Dr. Àlex Bayés Puig advances SYNGAP1 research with new SynGAP biomarker study funded by CURE SYNGAP1
CURE SYNGAP1, a 501(c)(3) organization, is proud to announce the award of a $25,000 grant to Dr. Àlex Bayés Puig, Group ...
Marvel Biosciences’ lead therapeutic candidate, MB-204 receives Japanese patent: Calgary, Alberta Thursday, February 5, 2026, 10:00 Hrs [IST] Marvel Biosciences Corporation and ...
Despite decades of research, scientists struggle to understand the mental health implications of DNA. Researchers were able ...
The Ban Ki-moon Foundation, Paris Brain Institute and Vascular Brain Health Institute empower the next generation of ...
DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As respiratory health challenges increase globally ...
The study, which assessed the pharmacokinetics, safety, tolerability and immunogenicity of AVT80 compared to Entyvio® in ...
Dr. Ronald C. Kessler of Harvard Medical School explores his leadership of global psychiatric epidemiology. His surveys across 30+ countries established frameworks that guide mental health policy ...
The following article is an editorial originally published by Global Times. It is reproduced here for reference, and the ...
Explore the Q4 2025 Alger Weatherbie Specialized Growth Fund performance. Read about the top contributors and detractors in ...
DONGGUAN, GUANGDONG, CHINA, January 15, 2026 /EINPresswire.com/ -- As sleep disorders such as obstructive sleep apnea ...
Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for Mytesi ® ...
5d
Global Neurorehabilitation Landscape Transformed by Integrated Solutions from Leading Manufacturers
SHANGHAI, SHANGHAI, CHINA, January 20, 2026 /EINPresswire.com/ -- The global healthcare sector is witnessing a paradigm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results